Article
ARG1 Is a Potential Prognostic Marker in Metastatic Endometrial Cancer.
Reproductive sciences (Thousand Oaks, Calif.) - 1 Jun 2024
Tran Dinh Nam, Rozen Valery, Nguyen Loan Thi Kim, Jung Jin-Seok, Coghill Lyndon M, Hunter Mark I, Kim Tae Hoon, Yoo Jung-Yoon, Jeong Jae-Wook
Abstract excerpt
Endometrial cancer (EC) is the most common gynecologic malignancy. While the majority of patients present with early-stage and low-grade EC and have an excellent prognosis, a subset has metastatic disease at presentation or develops distant recurrence after initial treatment of the primary. However, the lack of prognostic biomarkers for metastatic EC is a critical barrier. Arginase 1 (ARG1) regulates the last...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
